MEDVi Cheaper Alternative 2026

MEDVi isn't the most expensive GLP-1 telehealth program on the market, but it isn't the cheapest either. And when you're paying out of pocket for medication every single month, even a $50 difference adds up fast. Over a year, that's $600 back in your pocket.

The question is whether you can find something cheaper without sacrificing the medical oversight that makes GLP-1 therapy safe and effective. The answer, in 2026, is yes. Several programs deliver physician-supervised care and quality compounded medications at price points below what MEDVi charges.

We broke down the real costs and what you get at each price point.

Why People Look for Cheaper MEDVi Alternatives

Cost is the most common reason patients switch GLP-1 providers, and the frustration usually falls into a few categories:

• Dose-dependent pricing. Starting prices look reasonable, but costs climb as you titrate up. The monthly rate at a maintenance dose may be significantly higher than what you paid during month one.
• Hidden fees. Some patients report being surprised by separate consultation fees, lab costs, or shipping charges that were not clearly communicated at enrollment.
• Long-term affordability. GLP-1 therapy isn't a short-term treatment for most patients. A program that feels affordable for three months may become unsustainable at six or twelve months.
• Value perception. When provider interactions are brief and infrequent, patients start questioning whether they're getting enough clinical value for what they're paying.

Finding a cheaper option isn't about finding the absolute lowest price. It's about finding the best value, which means the right balance of cost, clinical care, and medication quality.

Top Cheaper Alternatives to MEDVi in 2026

1. Henry Meds ($149/month)

Henry Meds consistently ranks among the most affordable GLP-1 programs available. At $149/month for compounded semaglutide, the price includes medication, provider consultations, and shipping. There are no separate fees for anything. What you see is what you pay.

The tradeoff is clinical depth. Henry Meds operates a simplified model with monthly provider check-ins rather than intensive physician oversight. For patients who are responding well to their medication and don't need frequent dosing adjustments, that level of care is often sufficient. For patients who need more hands-on management, it may not be enough.

Pros:

• $149/month flat rate, all-inclusive
• No hidden fees or dose-based pricing increases
• Simple enrollment with fast shipping
• No contracts

Cons:

• Basic medical oversight
• No lab monitoring included
• Limited to semaglutide

2. FormBlends ($199/month)

FormBlends costs slightly more than the cheapest options, but the value proposition is stronger. At $199/month for compounded semaglutide (or $249/month for tirzepatide), you get direct physician supervision, personalized dosing protocols, and access to peptide therapies that most competitors don't offer.

For patients leaving MEDVi because of cost, FormBlends may or may not be cheaper depending on your current MEDVi plan. Where it consistently wins on value is the clinical experience. Every dollar goes toward a physician who knows your case, adjusts your protocol based on your response, and is available when you have questions. There are no surprise charges and no contracts.

Pros:

• Physician-supervised care included in the monthly price
• Personalized protocols, not cookie-cutter dosing
• Access to peptide therapies (BPC-157 and others)
• Transparent pricing with no hidden fees

Cons:

• $50/month more than the cheapest competitors
• Smaller platform than some larger competitors

3. SkinnyRx ($149+/month)

SkinnyRx keeps its program simple and its prices low. The focus is exclusively on weight loss medications, and the no-frills approach translates to competitive pricing. Enrollment is fast, shipping is reliable, and the platform doesn't try to upsell you on services you don't need.

Pros:

• Competitive starting prices
• Focused, simplified program
• Quick enrollment

Cons:

• Less clinical oversight than physician-supervised programs
• No peptide therapy options
• Limited medication selection

4. Hims/Hers ($149+/month)

Hims operates at a scale that allows competitive pricing across its GLP-1 offerings. Starting prices are in line with the most affordable options, and the platform's size means you rarely deal with supply chain issues or shipping delays. The clinical model is high-volume, so don't expect extensive one-on-one provider time, but the operational experience is smooth.

Pros:

• Competitive starting prices
• Reliable supply chain and shipping
• Polished app and user experience

Cons:

• Pricing increases at higher doses
• High-volume model limits provider interaction
• No peptide therapies

5. Ro Body ($149+/month)

Ro starts at a competitive price point and includes lab monitoring that most programs charge extra for or skip entirely. The catch is that monthly costs increase as you titrate, so the long-term price may be higher than the starting rate suggests. Still, for patients who want clinical rigor at a reasonable entry price, Ro delivers.

Pros:

• Lab monitoring included
• Strong medical oversight
• Competitive starting price

Cons:

• Costs increase at higher doses
• Not available in every state
• No peptide options

Cost Comparison Table

Who Should Switch from MEDVi to Save Money

Switching providers purely for cost savings makes sense in certain situations, but not all of them:

• Your MEDVi costs have climbed with dose increases. If you started at a reasonable rate but are now paying significantly more at your maintenance dose, a flat-rate program like Henry Meds or FormBlends could save you hundreds per year.
• You're paying for services you don't use. If your MEDVi plan includes features or add-ons that you never take advantage of, a leaner program may be a better fit for your budget.
• You're stable on your current dose. Patients who have found their effective dose and aren't experiencing complications can often transition to a lower-cost provider without disruption.
• You want better value, not just a lower price. Sometimes the cheapest option isn't the best value. If you're paying MEDVi prices but getting minimal clinical engagement, a program like FormBlends may cost the same or less while delivering significantly more physician involvement.

If your current protocol is working well and your side effects are managed, think carefully before switching purely to save a small amount. The disruption may not be worth it for $20/month. But for savings of $50 or more, a switch is usually straightforward and worthwhile.

Frequently Asked Questions

Why is MEDVi more expensive than some alternatives?

Pricing differences in the GLP-1 telehealth space come down to business model, pharmacy partnerships, and overhead. Some programs negotiate better rates with compounding pharmacies or operate with lower overhead costs. Higher prices don't always mean better care, and lower prices don't always mean worse care. Evaluate what you're actually getting for the money.

Will I get the same medication at a cheaper program?

Compounded semaglutide and tirzepatide are produced by 503B compounding pharmacies regardless of which telehealth platform prescribes them. The active ingredient is the same. What can vary is the specific compounding pharmacy, formulation details, and quality standards. Look for programs that work with FDA-registered facilities.

Can I transfer my prescription from MEDVi to a cheaper provider?

GLP-1 telehealth programs typically write new prescriptions through their own affiliated providers and pharmacies. You won't transfer your MEDVi prescription directly. Instead, your new provider will evaluate you and write a new prescription based on your treatment history.

What is the cheapest safe option for GLP-1 therapy?

Programs like Henry Meds at $149/month offer the lowest price point with physician oversight included. If you go below that price range, scrutinize the program carefully. Extremely cheap GLP-1 programs may cut corners on medical supervision, pharmacy quality, or both.

Key Points

You don't need to overpay for GLP-1 therapy in 2026. The market is competitive enough that quality physician-supervised programs exist at multiple price points. Whether you prioritize the absolute lowest cost or the best value for your money, there are legitimate MEDVi alternatives that can reduce your monthly spend without compromising your care.

Looking for physician-supervised GLP-1 therapy at a fair price? FormBlends offers transparent, flat-rate pricing with personalized care and no contracts. See what your treatment plan would look like.